Skip to main content

Advertisement

SpringerLink
Log in

Depolarized Mitochondrial Membrane Potential and Elevated Calcium in Platelets of Sickle Cell Disease

  • ORIGINAL ARTICLE
  • Published:
Indian Journal of Hematology and Blood Transfusion Aims and scope Submit manuscript

Abstract

Hemolysis, a crucial feature of Sickle cell disease (SCD), is a key player for cellular activation leading to various complications including thrombosis. In response to hemolysis, platelets get activated and release components that are necessary for further platelet activation and aggregation. Thus, it is believed that platelets contribute to the development of thrombotic complications. Platelets in SCD are expected to be affected due to common cause of hemolysis. To measure the surface markers of platelets including P-Selectin, Phosphatidyl Serine and integrin αIIbβ3 in SCD patients and healthy controls in order to understand the status of the platelets in SCD. To measure the surface markers of activated platelets using flow cytometry. Since mitochondria and calcium play an important role in cellular functions, the mitochondrial membrane potential and calcium content of platelets in SCD were also evaluated using flow cytometry. In the present study, we have observed significant increase of calcium level in SCD platelets. Further, the loss of mitochondrial membrane potential in SCD platelets was found to be significantly higher when compared to platelets of healthy controls. Though the surface markers of activated platelets in SCD remain unchanged, increased level of calcium and mitochondrial membrane potential loss suggest that the platelets in SCD are more prone to become activated. In order to understand the status of the platelets in SCD, apart from the surface markers, it is also important to assess the calcium levels and mitochondrial membrane potential of platelets.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Quinn CT (2016) Minireview: clinical severity in sickle cell disease: the challenges of definition and prognostication. Exp Biol Med 241(7):679–688. https://doi.org/10.1177/1535370216640385

    Article  CAS  Google Scholar 

  2. Kavanagh PL, Fasipe TA, Wun T (2022) Sickle cell disease: a review. JAMA 328(1):57–68. https://doi.org/10.1001/jama.2022.10233

    Article  PubMed  CAS  Google Scholar 

  3. Rees DC, Williams TN, Gladwin MT (2010) Sickle-cell disease. Lancet (London, England) 376(9757):2018–2031. https://doi.org/10.1016/S0140-6736(10)61029-X

    Article  PubMed  CAS  Google Scholar 

  4. Annarapu GK, Nolfi-Donegan D, Reynolds, et al (2021) Mitochondrial reactive oxygen species scavenging attenuates thrombus formation in a murine model of sickle cell disease. JTH 19(9):2256–2262. https://doi.org/10.1111/jth.15298

    Article  PubMed  CAS  Google Scholar 

  5. Villagra J, Shiva S, Hunter LA et al (2007) Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin. Blood 110(6):2166–2172. https://doi.org/10.1182/blood-2006-12-061697

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Wun T, Paglieroni T, Rangaswami A et al (1998) Platelet activation in patients with sickle cell disease. Br J Haematol 100(4):741–749. https://doi.org/10.1046/j.1365-2141.1998.00627.x

    Article  PubMed  CAS  Google Scholar 

  7. Vogel S, Thein SL (2018) Platelets at the crossroads of thrombosis, inflammation and haemolysis. Br J Haematol 180(5):761–767. https://doi.org/10.1111/bjh.15117

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  8. Frelinger AL 3rd, Jakubowski JA, Brooks JK et al (2014) Platelet activation and inhibition in sickle cell disease (pains) study. Platelets 25(1):27–35. https://doi.org/10.3109/09537104.2013.770136

    Article  PubMed  CAS  Google Scholar 

  9. Osman Y, Vatte CB (2018) Study of platelet activation markers and plasma cytokines in sickle cell disease patients during vaso-occlusive pain crises. J Hematopathol 11:37–44. https://doi.org/10.1007/s12308-018-0322-6

    Article  Google Scholar 

  10. Thein MS, Igbineweka NE, Thein SL (2017) Sickle cell disease in the older adult. Pathology 49(1):1–9. https://doi.org/10.1016/j.pathol.2016.10.002

    Article  PubMed  Google Scholar 

  11. Yamakawa K, Ogura H, Koh T et al (2013) Platelet mitochondrial membrane potential correlates with severity in patients with systemic inflammatory response syndrome. J Trauma Acute Care Surg 74(2):411–418. https://doi.org/10.1097/TA.0b013e31827a34cf

    Article  PubMed  CAS  Google Scholar 

  12. Kraemer BF, Hennis I, Karge A et al (2022) Platelet mitochondrial membrane depolarization reflects disease severity in patients with preeclampsia. Mol Med (Camb, MA) 28(1):51. https://doi.org/10.1186/s10020-022-00472-x

    Article  CAS  Google Scholar 

  13. Gründler K, Angstwurm M, Hilge R et al (2014) Platelet mitochondrial membrane depolarization reflects disease severity in patients with sepsis and correlates with clinical outcome. Crit Care (Lond, Engl) 18(1):R31. https://doi.org/10.1186/cc13724

    Article  Google Scholar 

  14. Kaiser R, Escaig R, Kranich J et al (2022) Procoagulant platelet sentinels prevent inflammatory bleeding through GPIIBIIIA and PVI. Blood 140(2):121–139. https://doi.org/10.1182/blood.2021014914

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  15. Jardín I, López JJ, Pariente JA et al (2008) Intracellular calcium release from human platelets: different messengers for multiple stores. Trends Cardiovasc Med 18(2):57–61. https://doi.org/10.1016/j.tcm.2007.12.004

    Article  PubMed  CAS  Google Scholar 

  16. Kannan M, Ahmad F, Saxena R (2019) Platelet activation markers in evaluation of thrombotic risk factors in various clinical settings. Blood reviews 37:100583. https://doi.org/10.1016/j.blre.2019.05.007

    Article  PubMed  CAS  Google Scholar 

  17. Brass LF, Shattil SJ (1984) Identification and function of the high affinity binding sites for Ca2+ on the surface of platelets. J Clin Investig 73(3):626–632. https://doi.org/10.1172/JCI111252

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Varga-Szabo D, Braun A, Nieswandt B (2009) Calcium signaling in platelets. J Thromb Haemost 7(7):1057–1066. https://doi.org/10.1111/j.1538-7836.2009.03455.x

    Article  PubMed  CAS  Google Scholar 

  19. Kannan M, Ahmad F, Yadav BK et al (2008) Carrier detection in Glanzmann thrombasthenia: comparison of flow cytometry and Western blot with respect to DNA mutation. Am J Clin Pathol 130(1):93–98. https://doi.org/10.1309/HYE4AP9961CEP0C0

    Article  PubMed  Google Scholar 

  20. Kannan M, Ahmad F, Yadav BK et al (2009) Molecular defects in ITGA2B and ITGB3 genes in patients with Glanzmann thrombasthenia. JTH 7(11):1878–1885. https://doi.org/10.1111/j.1538-7836.2009.03579.x

    Article  PubMed  CAS  Google Scholar 

  21. Jakubowski JA, Zhou C, Winters KJ et al (2015) The effect of prasugrel on ADP-stimulated markers of platelet activation in patients with sickle cell disease. Platelets 26(5):474–479. https://doi.org/10.3109/09537104.2014.940887

    Article  PubMed  CAS  Google Scholar 

  22. Berney SI, Ridler CD, Stephens AD et al (1992) Enhanced platelet reactivity and hypercoagulability in the steady state of sickle cell anaemia. Am J Hematol 40(4):290–294. https://doi.org/10.1002/ajh.2830400409

    Article  PubMed  CAS  Google Scholar 

  23. Tomer A, Harker LA, Kasey S et al (2001) Thrombogenesis in sickle cell disease. J Lab Clin Med 137(6):398–407. https://doi.org/10.1067/mlc.2001.115450

    Article  PubMed  CAS  Google Scholar 

  24. Brunson A, Keegan T, Mahajan A et al (2019) High incidence of venous thromboembolism recurrence in patients with sickle cell disease. Am J Hematol 94(8):862–870. https://doi.org/10.1002/ajh.25508

    Article  PubMed  PubMed Central  Google Scholar 

  25. Naik RP, Streiff MB, Haywood C et al (2014) Venous thromboembolism incidence in the cooperative study of sickle cell disease. JTH 12(12):2010–2016. https://doi.org/10.1111/jth.12744

    Article  PubMed  CAS  Google Scholar 

  26. Jedlička J, Kunc R, Kuncová J (2021) Mitochondrial respiration of human platelets in young adult and advanced age - Seahorse or O2k? Physiol Res https://doi.org/10.33549/physiolres.934812

  27. Palacka P, Gvozdjáková A, Rausová Z et al (2021) Platelet mitochondrial bioenergetics reprogramming in patients with urothelial carcinoma. Int J Mol Sci 23(1):388. https://doi.org/10.3390/ijms23010388

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  28. Wang Z, Cai F, Hu L et al (2014) The role of mitochondrial permeability transition pore in regulating the shedding of the platelet GPIbα. Ectodomain. Platelets 25(5):373–381. https://doi.org/10.3109/09537104.2013.821604

    Article  PubMed  CAS  Google Scholar 

  29. Jobe SM, Wilson KM, Leo L et al (2008) Critical role for the mitochondrial permeability transition pore and cyclophilin D in platelet activation and thrombosis. Blood 111(3):1257–1265. https://doi.org/10.1182/blood-2007-05-092684

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. Cardenes N, Corey C, Geary L et al (2014) Platelet bioenergetic screen in sickle cell patients reveals mitochondrial complex V inhibition, which contributes to platelet activation. Blood 123(18):2864–2872. https://doi.org/10.1182/blood-2013-09-529420

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Acknowledgements

The authors thank the funding agency, Science and Engineering Research Board, Department of Science and Technology (DST-SERB), Government of India, INDIA (Grant ID: EMR/2016/000955) for supporting this study. The authors also thank the participants who volunteered for this study.

Author information

Authors and Affiliations

  1. Division of Blood and Vascular Biology, Department of Life Sciences, School of Life Sciences, Central University of Tamil Nadu, Tiruvarur, 610 101, India

    Samarjit Maharana, Chitrali Laha Roy & Meganathan Kannan

  2. Department of Hematology, All India Institute of Medical Sciences, New Delhi, India

    Kamal Kishor, Ravi Ranjan, Manoranjan Mahapatra & Renu Saxena

  3. Department of Basic Medical Sciences, College of Medicine, University of Sharjah, Sharjah, UAE

    Firdos Ahmad

Authors
  1. Samarjit Maharana
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chitrali Laha Roy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kamal Kishor
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ravi Ranjan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Firdos Ahmad
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Manoranjan Mahapatra
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Renu Saxena
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Meganathan Kannan
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

SM, CLR and KK collected samples, performed experiments and collected data. RR helped with the sample collection and clinical data collection. FA critically revised the manuscript for important intellectual content. RS and MM supported the clinical data, interpreted and validated the manuscript. MK designed the study, supervised the project, interpreted the data and wrote the manuscript. All authors have approved the final article.

Corresponding author

Correspondence to Meganathan Kannan.

Ethics declarations

Conflict of interest

The authors have no conflicts of interests.

Ethical approval

This study was approved by the institutional human ethics committee (IEC-514). All procedures followed were in accordance with the ethical standards of the institutional committee on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008 (5). All persons gave their informed consent prior to their inclusion in the study. Informed consent was obtained from all patients for being included in the study.

Consent to participate

Informed consent had been taken from the participants of this study.

Consent for publication

Consent for publication had been taken from all the contributing authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Maharana, S., Roy, C.L., Kishor, K. et al. Depolarized Mitochondrial Membrane Potential and Elevated Calcium in Platelets of Sickle Cell Disease. Indian J Hematol Blood Transfus 39, 565–571 (2023). https://doi.org/10.1007/s12288-023-01640-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12288-023-01640-7

Keywords

Search

Navigation